Annual Shareholders Equity
$106.02 M
-$30.83 M-22.53%
December 31, 2023
Summary
- As of February 7, 2025, ABUS annual stockholders equity is $106.02 million, with the most recent change of -$30.83 million (-22.53%) on December 31, 2023.
- During the last 3 years, ABUS annual shareholders equity has risen by +$4.05 million (+3.97%).
- ABUS annual shareholders equity is now -80.64% below its all-time high of $547.68 million, reached on December 31, 2015.
Performance
ABUS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$106.89 M
-$15.56 M-12.71%
September 30, 2024
Summary
- As of February 7, 2025, ABUS quarterly stockholders equity is $106.89 million, with the most recent change of -$15.56 million (-12.71%) on September 30, 2024.
- Over the past year, ABUS quarterly shareholders equity has dropped by -$7.75 million (-6.76%).
- ABUS quarterly shareholders equity is now -82.00% below its all-time high of $593.69 million, reached on March 31, 2015.
Performance
ABUS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ABUS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.5% | -6.8% |
| 3 y3 years | +4.0% | -21.9% |
| 5 y5 years | -47.0% | -21.9% |
ABUS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.4% | at low | -36.9% | +0.8% |
| 5 y | 5-year | -37.4% | +45.7% | -36.9% | +63.2% |
| alltime | all time | -80.6% | +673.3% | -82.0% | >+9999.0% |
Arbutus Biopharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $106.89 M(-12.7%) |
| Jun 2024 | - | $122.45 M(+6.8%) |
| Mar 2024 | - | $114.64 M(+8.1%) |
| Dec 2023 | $106.02 M(-22.5%) | $106.02 M(-11.2%) |
| Sep 2023 | - | $119.34 M(-11.4%) |
| Jun 2023 | - | $134.69 M(-6.4%) |
| Mar 2023 | - | $143.91 M(+5.2%) |
| Dec 2022 | $136.85 M(-19.2%) | $136.85 M(-6.0%) |
| Sep 2022 | - | $145.52 M(-5.0%) |
| Jun 2022 | - | $153.14 M(-7.7%) |
| Mar 2022 | - | $165.84 M(-2.1%) |
| Dec 2021 | $169.44 M(+66.2%) | $169.44 M(+30.2%) |
| Sep 2021 | - | $130.14 M(+29.1%) |
| Jun 2021 | - | $100.83 M(-11.7%) |
| Mar 2021 | - | $114.15 M(+11.9%) |
| Dec 2020 | $101.97 M(+40.2%) | $101.97 M(+4.7%) |
| Sep 2020 | - | $97.34 M(+48.6%) |
| Jun 2020 | - | $65.51 M(-10.6%) |
| Mar 2020 | - | $73.26 M(+0.7%) |
| Dec 2019 | $72.74 M(-63.7%) | $72.74 M(-13.0%) |
| Sep 2019 | - | $83.64 M(-49.1%) |
| Jun 2019 | - | $164.47 M(-9.2%) |
| Mar 2019 | - | $181.21 M(-9.5%) |
| Dec 2018 | $200.23 M(+9.7%) | $200.23 M(-7.0%) |
| Sep 2018 | - | $215.27 M(-9.6%) |
| Jun 2018 | - | $238.07 M(+2.4%) |
| Mar 2018 | - | $232.42 M(+27.4%) |
| Dec 2017 | $182.47 M(-10.1%) | $182.47 M(+9.0%) |
| Sep 2017 | - | $167.39 M(-4.8%) |
| Jun 2017 | - | $175.79 M(-7.0%) |
| Mar 2017 | - | $189.10 M(-6.9%) |
| Dec 2016 | $203.00 M(-62.9%) | $203.00 M(-51.3%) |
| Sep 2016 | - | $416.63 M(-3.4%) |
| Jun 2016 | - | $431.32 M(-19.8%) |
| Mar 2016 | - | $538.08 M(-1.8%) |
| Dec 2015 | $547.68 M(+522.1%) | $547.68 M(-1.1%) |
| Sep 2015 | - | $553.81 M(-5.9%) |
| Jun 2015 | - | $588.50 M(-0.9%) |
| Mar 2015 | - | $593.69 M(+574.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $88.03 M(+48.7%) | $88.03 M(-7.8%) |
| Sep 2014 | - | $95.50 M(-9.2%) |
| Jun 2014 | - | $105.14 M(-0.3%) |
| Mar 2014 | - | $105.48 M(+78.2%) |
| Dec 2013 | $59.19 M(+44.7%) | $59.19 M(+98.4%) |
| Sep 2013 | - | $29.84 M(-12.3%) |
| Jun 2013 | - | $34.02 M(-10.2%) |
| Mar 2013 | - | $37.87 M(-7.5%) |
| Dec 2012 | $40.92 M(+686.0%) | $40.92 M(>+9900.0%) |
| Sep 2012 | - | $314.10 K(-91.1%) |
| Jun 2012 | - | $3.54 M(-34.3%) |
| Mar 2012 | - | $5.39 M(+3.5%) |
| Dec 2011 | $5.21 M(-51.5%) | $5.21 M(-21.7%) |
| Sep 2011 | - | $6.65 M(-21.1%) |
| Jun 2011 | - | $8.42 M(+6.0%) |
| Mar 2011 | - | $7.95 M(-25.9%) |
| Dec 2010 | $10.73 M(-50.0%) | $10.73 M(-58.0%) |
| Sep 2010 | - | $25.54 M(-6.9%) |
| Jun 2010 | - | $27.43 M(-15.4%) |
| Mar 2010 | - | $32.42 M(+51.1%) |
| Dec 2009 | $21.45 M(-44.0%) | $21.45 M(-42.2%) |
| Sep 2009 | - | $37.12 M(+1.5%) |
| Jun 2009 | - | $36.58 M(+3.5%) |
| Mar 2009 | - | $35.35 M(-7.7%) |
| Dec 2008 | $38.29 M(+108.4%) | $38.29 M(-17.9%) |
| Sep 2008 | - | $46.64 M(-14.0%) |
| Jun 2008 | - | $54.26 M(+214.0%) |
| Mar 2008 | - | $17.28 M(-5.9%) |
| Dec 2007 | $18.37 M(>+9900.0%) | $18.37 M(+2.5%) |
| Sep 2007 | - | $17.92 M(+18.9%) |
| Jun 2007 | - | $15.07 M |
| Dec 2006 | $155.50 K(-100.8%) | - |
| Dec 2005 | -$18.49 M(+76.2%) | - |
| Dec 2004 | -$10.50 M(-169.7%) | - |
| Dec 2003 | $15.05 M(-21.5%) | - |
| Dec 2002 | $19.18 M(-68.8%) | - |
| Dec 2001 | $61.49 M(+104.8%) | - |
| Dec 2000 | $30.03 M(+11.7%) | - |
| Dec 1999 | $26.88 M(+86.3%) | - |
| Dec 1998 | $14.43 M | - |
FAQ
- What is Arbutus Biopharma annual stockholders equity?
- What is the all time high annual shareholders equity for Arbutus Biopharma?
- What is Arbutus Biopharma annual shareholders equity year-on-year change?
- What is Arbutus Biopharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly shareholders equity year-on-year change?
What is Arbutus Biopharma annual stockholders equity?
The current annual shareholders equity of ABUS is $106.02 M
What is the all time high annual shareholders equity for Arbutus Biopharma?
Arbutus Biopharma all-time high annual stockholders equity is $547.68 M
What is Arbutus Biopharma annual shareholders equity year-on-year change?
Over the past year, ABUS annual stockholders equity has changed by -$30.83 M (-22.53%)
What is Arbutus Biopharma quarterly stockholders equity?
The current quarterly shareholders equity of ABUS is $106.89 M
What is the all time high quarterly shareholders equity for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly stockholders equity is $593.69 M
What is Arbutus Biopharma quarterly shareholders equity year-on-year change?
Over the past year, ABUS quarterly stockholders equity has changed by -$7.75 M (-6.76%)